These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 9284132)
21. Use of antigens derived from Burkholderia pseudomallei, B. thailandensis, and B. cepacia in the indirect hemagglutination assay for melioidosis. Gilmore G; Barnes J; Ketheesan N; Norton R Clin Vaccine Immunol; 2007 Nov; 14(11):1529-31. PubMed ID: 17804613 [TBL] [Abstract][Full Text] [Related]
22. Molecular and physical characterization of Burkholderia mallei O antigens. Burtnick MN; Brett PJ; Woods DE J Bacteriol; 2002 Feb; 184(3):849-52. PubMed ID: 11790757 [TBL] [Abstract][Full Text] [Related]
23. Rapid and Sensitive Multiplex Detection of Burkholderia pseudomallei-Specific Antibodies in Melioidosis Patients Based on a Protein Microarray Approach. Kohler C; Dunachie SJ; Müller E; Kohler A; Jenjaroen K; Teparrukkul P; Baier V; Ehricht R; Steinmetz I PLoS Negl Trop Dis; 2016 Jul; 10(7):e0004847. PubMed ID: 27427979 [TBL] [Abstract][Full Text] [Related]
24. Antigenic relatedness between Burkholderia pseudomallei and Burkholderia mallei. Anuntagool N; Sirisinha S Microbiol Immunol; 2002; 46(3):143-50. PubMed ID: 12008922 [TBL] [Abstract][Full Text] [Related]
25. Burkholderia pseudomallei-specific recombinant protein and its potential in the diagnosis of melioidosis. Wongprompitak P; Thepthai C; Songsivilai S; Dharakul T Asian Pac J Allergy Immunol; 2001 Mar; 19(1):37-41. PubMed ID: 11495298 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of lipopolysaccharide and capsular polysaccharide as subunit vaccines against experimental melioidosis. Nelson M; Prior JL; Lever MS; Jones HE; Atkins TP; Titball RW J Med Microbiol; 2004 Dec; 53(Pt 12):1177-1182. PubMed ID: 15585494 [TBL] [Abstract][Full Text] [Related]
27. Structural and immunological characterization of Burkholderia pseudomallei O-polysaccharide-flagellin protein conjugates. Brett PJ; Woods DE Infect Immun; 1996 Jul; 64(7):2824-8. PubMed ID: 8698517 [TBL] [Abstract][Full Text] [Related]
28. Seropositivity to Burkholderia pseudomallei does not reflect the development of cell-mediated immunity. Lazzaroni SM; Barnes JL; Williams NL; Govan BL; Norton RE; LaBrooy JT; Ketheesan N Trans R Soc Trop Med Hyg; 2008 Dec; 102 Suppl 1():S66-70. PubMed ID: 19121692 [TBL] [Abstract][Full Text] [Related]
29. Development of Immunoassays for Nualnoi T; Norris MH; Tuanyok A; Brett PJ; Burtnick MN; Keim PS; Settles EW; Allender CJ; AuCoin DP Am J Trop Med Hyg; 2017 Feb; 96(2):358-367. PubMed ID: 27994103 [No Abstract] [Full Text] [Related]
31. Distinct classes and subclasses of antibodies to hemolysin co-regulated protein 1 and O-polysaccharide and correlation with clinical characteristics of melioidosis patients. Pumpuang A; Phunpang R; Ekchariyawat P; Dulsuk A; Loupha S; Kwawong K; Charoensawat Y; Thiansukhon E; Day NPJ; Burtnick MN; Brett PJ; West TE; Chantratita N Sci Rep; 2019 Sep; 9(1):13972. PubMed ID: 31562344 [TBL] [Abstract][Full Text] [Related]
32. Evidence of Burkholderia pseudomallei-specific immunity in patient sera persistently nonreactive by the indirect hemagglutination assay. Harris PN; Williams NL; Morris JL; Ketheesan N; Norton RE Clin Vaccine Immunol; 2011 Aug; 18(8):1288-91. PubMed ID: 21677111 [TBL] [Abstract][Full Text] [Related]
33. Role of Burkholderia pseudomallei-Specific IgG2 in Adults with Acute Melioidosis, Thailand. Chaichana P; Jenjaroen K; Chumseng S; Sumonwiriya M; Rongkard P; Kronsteiner B; Teparrukkul P; Limmathurotsakul D; Day NPJ; Chantratita N; Dunachie SJ Emerg Infect Dis; 2021 Feb; 27(2):463-470. PubMed ID: 33496230 [TBL] [Abstract][Full Text] [Related]
34. Human single-chain Fv antibodies against Burkholderia mallei and Burkholderia pseudomallei. Zou N; Newsome T; Li B; Tsai S; Lo SC Exp Biol Med (Maywood); 2007 Apr; 232(4):550-6. PubMed ID: 17392491 [TBL] [Abstract][Full Text] [Related]
35. The wbiA locus is required for the 2-O-acetylation of lipopolysaccharides expressed by Burkholderia pseudomallei and Burkholderia thailandensis. Brett PJ; Burtnick MN; Woods DE FEMS Microbiol Lett; 2003 Jan; 218(2):323-8. PubMed ID: 12586411 [TBL] [Abstract][Full Text] [Related]
36. Burkholderia pseudomallei antibodies in individuals living in endemic regions in Northeastern Brazil. Rolim DB; Vilar DC; de Góes Cavalcanti LP; Freitas LB; Inglis TJ; Nobre Rodrigues JL; Nagao-Dias AT Am J Trop Med Hyg; 2011 Feb; 84(2):302-5. PubMed ID: 21292903 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of Polysaccharide-Based Latex Agglutination Assays for the Rapid Detection of Antibodies to Burkholderia pseudomallei. Suttisunhakul V; Chantratita N; Wikraiphat C; Wuthiekanun V; Douglas Z; Day NPJ; Limmathurotsakul D; Brett PJ; Burtnick MN Am J Trop Med Hyg; 2015 Sep; 93(3):542-546. PubMed ID: 26123956 [TBL] [Abstract][Full Text] [Related]
38. Passive protection against Burkholderia pseudomallei infection in mice by monoclonal antibodies against capsular polysaccharide, lipopolysaccharide or proteins. Jones SM; Ellis JF; Russell P; Griffin KF; Oyston PCF J Med Microbiol; 2002 Dec; 51(12):1055-1062. PubMed ID: 12466403 [TBL] [Abstract][Full Text] [Related]
39. Survey of innate immune responses to Burkholderia pseudomallei in human blood identifies a central role for lipopolysaccharide. Chantratita N; Tandhavanant S; Myers ND; Seal S; Arayawichanont A; Kliangsa-Ad A; Hittle LE; Ernst RK; Emond MJ; Wurfel MM; Day NP; Peacock SJ; West TE PLoS One; 2013; 8(11):e81617. PubMed ID: 24303060 [TBL] [Abstract][Full Text] [Related]